Celgene Germany

Celgene is a global biopharmaceutical company founded at 1986 in New Jersey, USA. The company explores, develops and markets innovative medicines mainly for the treatment of cancer and diseases of the immune system. Celgene is represented in Germany since 2006 by Celgene GmbH in Munich-Riem.

In cooperation with selected medical institutions worldwide, Celgene has currently more than 200 clinical studies. These innovative materials used in its pipeline show convincing results in the treatment of diseases of the hematopoietic system. These include multiple myeloma called myelodysplastic syndromes, chronic lymphatic leukemia and non-Hodgkin's lymphoma. Moreover, promising results are already present in the treatment of solid tumors of the ovary, pancreas and prostate.
Address: Joseph-Wild-Strasse 20 81829 München, Germany
Website: www.celgene.de
Phone: 49-89-451519010
Email: info@celgene.de
 
This website requires Flash Player 9 or later. If you can not view this site you probably need to update your system with this plug-in for your browser.